Obesity, combined or not with MetS, creates a higher risk of developing CKD, predisposing to a pro-inflammatory state, increased IL-6 and TNF-α and possible progression of kidney injury to terminal CKD [47, 48]. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.